Literature DB >> 17536077

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

William H Herman1, Yong Ma, Gabriel Uwaifo, Steven Haffner, Steven E Kahn, Edward S Horton, John M Lachin, Maria G Montez, Tina Brenneman, Elizabeth Barrett-Connor.   

Abstract

OBJECTIVE: We sought to examine racial and ethnic differences in A1C in individuals with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS: We studied 3,819 individuals aged > or = 25 years with IGT who were found to be eligible to participant in the Diabetes Prevention Program. A1C was compared among five racial and ethnic groups before and after adjustment for factors that differed among groups or might affect glycemia including age, sex, education, marital status, blood pressure, adiposity (BMI and waist circumference), hematocrit, fasting and post-glucose load glucose levels, glucose area under the curve (AUC), beta-cell function, and insulin resistance.
RESULTS: Mean +/- SD A1C was 5.91 +/- 0.50%. Among whites, A1C was 5.80 +/- 0.44%, among Hispanics 5.89 +/- 0.46%, among Asian 5.96 +/- 0.45%, among American Indians 5.96 +/- 0.46%, and among blacks 6.19 +/- 0.59%. Age, sex, systolic blood pressure, diastolic blood pressure, BMI, fasting glucose, glucose AUC, corrected insulin response, and insulin resistance were each independent predictors of A1C. Adjusting for these and other factors, mean A1C levels were 5.78% for whites, 5.93% for Hispanics, 6.00% for Asians, 6.12% for American Indians, and 6.18% for blacks (P < 0.001).
CONCLUSIONS: A1C levels are higher among U.S. racial and ethnic minority groups with IGT after adjustment for factors likely to affect glycemia. Among patients with IGT, A1C may not be valid for assessing and comparing glycemic control across racial and ethnic groups or as an indicator of health care disparities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536077      PMCID: PMC2373980          DOI: 10.2337/dc06-2003

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

2.  Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization.

Authors:  Tiffany L Gary; Maura McGuire; Jeanne McCauley; Frederick L Brancati
Journal:  Dis Manag       Date:  2004

3.  Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial.

Authors:  Grace Mariko Kalish; Elizabeth Barrett-Connor; Gail A Laughlin; Barbara I Gulanski
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

Review 4.  Glycated hemoglobin: methodologies and clinical applications.

Authors:  D E Goldstein; R R Little; H M Wiedmeyer; J D England; E M McKenzie
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

5.  HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins.

Authors:  H Snieder; P A Sawtell; L Ross; J Walker; T D Spector; R D Leslie
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

6.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

7.  Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes.

Authors:  Ghislain Delpierre; François Collard; Juliette Fortpied; Emile Van Schaftingen
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

8.  Haemoglobin A1c concentrations in men and women with diabetes.

Authors:  M H Stickland; R C Paton; J K Wales
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

9.  Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey.

Authors:  Jinan B Saaddine; Anne Fagot-Campagna; Deborah Rolka; K M Venkat Narayan; Linda Geiss; Mark Eberhardt; Katherine M Flegal
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

10.  Health behaviors and quality of care among Latinos with diabetes in managed care.

Authors:  Arleen F Brown; Robert B Gerzoff; Andrew J Karter; Edward Gregg; Monika Safford; Beth Waitzfelder; Gloria L A Beckles; Rebecca Brusuelas; Carol M Mangione
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

View more
  206 in total

1.  HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?

Authors:  Robert M Cohen; Shannon Haggerty; William H Herman
Journal:  J Clin Endocrinol Metab       Date:  2010-12       Impact factor: 5.958

2.  Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic states.

Authors:  Stefan S Fajans; William H Herman; Elif A Oral
Journal:  Metabolism       Date:  2010-08-17       Impact factor: 8.694

Review 3.  Is There a Role for HbA1c in Pregnancy?

Authors:  Ruth C E Hughes; Janet Rowan; Chris M Florkowski
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

4.  Methods needed to measure predictive accuracy: A study of diabetic patients.

Authors:  Hafiz M R Khan; Sarah Mende; Aamrin Rafiq; Kemesha Gabbidon; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-11       Impact factor: 5.187

5.  Pitfalls of HbA1c in the Diagnosis of Diabetes.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; João Sérgio Neves; Mariana P Monteiro; Jose Luiz Medina; Brenda Dorcely; Martin Buysschaert
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

6.  Diabetes mellitus in centenarians.

Authors:  Adam Davey; Uday Lele; Merrill F Elias; Gregory A Dore; Ilene C Siegler; Mary A Johnson; Dorothy B Hausman; J Lisa Tenover; Leonard W Poon
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

7.  Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.

Authors:  Mayer B Davidson; Petra Duran; Martin L Lee
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

8.  Racial disparities in outcomes following PEA and asystole in-hospital cardiac arrests.

Authors:  Rabia R Razi; Matthew M Churpek; Trevor C Yuen; Monica E Peek; Thomas Fisher; Dana P Edelson
Journal:  Resuscitation       Date:  2014-12-09       Impact factor: 5.262

Review 9.  HbA1c for screening and diagnosis of diabetes mellitus.

Authors:  Trefor Higgins
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

10.  Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.

Authors:  Jennifer Elston Lafata; Andrew J Karter; Patrick J O'Connor; Heather Morris; Julie A Schmittdiel; Scott Ratliff; Katherine M Newton; Marsha A Raebel; Ram D Pathak; Abraham Thomas; Melissa G Butler; Kristi Reynolds; Beth Waitzfelder; John F Steiner
Journal:  J Gen Intern Med       Date:  2016-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.